ReleaseWire Connect

We have trimmed our growth forecasts for Indonesia in 2012 and 2013, but only marginally so. BMI's view is that the slowdown in the global economy, and in Chinese growth which will for the first time in the last decade come in at under 8%, will have a knock-on effect on Indonesia. On the other hand, the country's domestic economy is in fairly rude health, with consumer spending looking solid and investment also performing well as the government and the private sector begin to tackle the often postponed need to expand and update infrastructure. BMI now expects the Indonesian economy to grow by 5.8% in 2012 (down from 5.9% in our last quarterly report); our outlook is for GDP growth of 6.2% in 2013 (was 6.3%). In the five years to 2016 we expect growth to average 6.2% per annum, confirming the country as a regional outperformer.

BMI View: South African IT spending to increase to about US$17.6bn in 2016, at a US dollar 2012-2016 CAGR of 10%, slower than previously forecast. Major infrastructure and transport projects will provide encouragement for growth during BMI's five-year forecast period. Most opportunities are likely to be in sectors such as wholesale and retail trade and financial and personal services, which will grow faster, while other verticals like mining and manufacturing suffer a slowdown. However, South African businesses are expected to maintain a cautious attitude to IT investments, due to continued global economic uncertainty.

BMI View: Oil production in Norway may be in decline, but the country retains considerable upside gas potential and should continue to be a major force in European energy supply for decades to come. Discoveries of considerable size are clearly still possible, with the Sverdrup (formerly Aldous/Avaldsnes) prospect containing a potential 2.2-2.8bn barrels of recoverable oil. This should stimulate fresh investment on the part of domestic and foreign operators and delay any decline in output.

Kuwait's ports have struggled to recover the volumes they enjoyed prior to the global economic downturn, but BMI expects this largely to be achieved in 2012, with only total tonnage throughput at Shuaiba not forecast to recoup lost levels until 2013. If there are continued instances of industrial unrest and strikes, however, as Kuwait's ports have struggled with since the Arab Spring of 2011, then we may have to revise our forecasts down. The air freight sector was also hit in 2011, with volumes actually falling. 2012 has not started well, and we are forecasting very slow growth in tonnage at Kuwait International Airport in 2012.

Following a year in which BMI saw signs of recovery, 2012 will signal further growth, albeit it at a slower pace on the back of the macroeconomic outlook.

Augmented Reality or simply AR is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input, that enrich the user's perception of the real world. Although AR is often perceived to be in the visual domain (video or graphics etc), it actually includes the other senses as well such as sound or GPS data.

Glycominds Ltd. (GML), a medical device provider, based in Israel. It develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. The company's products include gMS DX, gMS Pro EDSS and IBDX. Its gMS Dx test provides clinically valuable information clinicians can use to help make decisions about the likelihood of having Multiple Sclerosis. Glycominds' technology platform assesses the immune response by measuring the level of antibody biomarkers against glycans. The company's gMS tests help physicians identify patients who have Multiple Sclerosis and which of these patients are likely to progress towards disability. GML is headquartered in Lod, Israel.

Pronota NV (Pronota) is a developer of biomarker discovery, based in Belgium. It focuses on protein biomarkers for identification of candidates for drug development and diagnostic products for diagnosis and personalized treatment of diseases. The company's products include cardio-rendal, pre-eclampsia, sepsis, and ovarian cancer. Its technologies include MASStermind, a protein biomarker discovery platform that enables the identification and relative quantitation of proteins; and MASSterclass, a mass spectrometry based antibody-free assay platform that provides contract assay development and biomarker screening services. The company also provides contract proteomic research and development services to the pharmaceutical and diagnostic industry. Pronota is headquartered in Zwijnaarde, Belgium.

GlobalData's report, Styrene-Butadiene Rubber (SBR) Industry Outlook in India to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of India SBR industry. The research presents major market trends affecting the SBR industry in India. The report covers India SBR plants and presents installed capacity by key feedstock, process and technology. In addition, it presents SBR demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major SBR producers in India. Overall, the report presents a comprehensive coverage of India SBR industry including all the major parameters.